Relationship between insulin and carotid atherosclerosis in the general population: The Bruneck study

Stroke

Volumn 28, Issue 6, 1997, Pages 1147-1152

  Bonora, E ^a   Willeit, J ^b   Kiechl, S ^b   Oberhollenzer, F ^b   Egger, G ^b   Bonadonna, R ^b   Muggeo, M ^b  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b NONE

Author keywords

Carotid artery disease; Insulin; Risk factors

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030913817     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.6.1147     Document Type: Article

References (49)

1. Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL. Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol. 1983;118:326-337.
2. Modan M, Halkin H, Almong S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest. 1985;75:809-817.
3. Bonora E, Zavaroni I, Alpi O, Pezzarossa A, Bruschi F, Dall'Aglio E, Guerra L, Coscelli C, Butturini U. Relationship between blood pressure and plasma insulin in nonobese and obese nondiabetic subjects. Diabetologia. 1987;30:719-723.
4. Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects. Metabolism. 1986;35: 250-253.
5. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven G. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med. 1989;320:703-706.
6. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34:416-422.
7. Haffner SM, Valdez RA, Hazuda HH, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes. 1992;41:715-722.
8. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentration. Diabetes Care. 1979;2:154-160.
9. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1979;2:131-141.
10. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-age population. Diabetologia. 1980;19:205-210.
11. Pyorala K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study Population. Acta Med Scand. 1985; 701(suppl):38-52.
12. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwege E. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia. 1991;34:356-361.
13. Welborn TA, Knuiman MW, Ward N, Whittal DE. Serum insulin is a risk marker for coronary heart disease mortality in men but not in women. Diabetes Res Clin Pract. 1994;26:51-59.
14. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-957.
15. O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK, Bommer WB, Price TR, Gardin JM, Savage PJ, for the CHS Collaborative Research Group. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke. 1992;23:1752-1760.
16. Folsom AR, Eckfeldt JH, Weitzman S, Jing M, Chambless LE, Barnes RW, Cram KB, Hutchinson RG. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke. 1994;25:66-73.
17. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R, for the IRAS Investigators. Insulin sensitivity and atherosclerosis: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 1996; 93:1809-1817.
18. Willeit J, Kiechl S. Prevalence and risk factors of asymptomatic extra-cranial carotid artery atherosclerosis: a population-based study. Arterioscler Thromb. 1993;13:661-668.
19. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039-1057.
20. Bray GA. An approach to the classification and evaluation of obesity. In: Bjorntorp P, Brodoff BN, eds. Obesity. Philadelphia, Pa: JB Lippincott Co; 1992:294-308.
21. World Health Organization. Arterial Hypertension: Report of a WHO Study Group. Geneva, Switzerland: World Health Organization; Tech Rep Ser 628; 1978:9-17.
22. Hales CN, Randle PJ. Immunoassay of insulin with insulin-antibody precipitate. Biochem J. 1963;88:137-144.
23. Landis JR, Koch GG. Measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
24. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons; 1988.
25. Hosmer DW, Lemeshow S. Goodness-of-fit tests for multiple logistic regression model. Comm Stat Part A Theor Methods. 1980; A9:1043-1069.
26. Lynch J, Kaplan GA, Salonen R, Cohen RD, Salonen JT. Socioeconomic status and carotid atherosclerosis. Circulation. 1995;92: 1786-1792.
27. McKeigue P, Davey G. Associations between insulin levels and cardiovascular disease are confounded by comorbidity. Diabetes Care. 1995;18:1294-1298.
28. Kiechl S, Willeit J, Egger G, Oberhollenzer M, Aichner F. Alcohol consumption and carotid atherosclerosis: evidence of dose-dependent atherogenic and anti-atherogenic effects - results from the Bruneck Study. Stroke. 1994;25:1593-1598.
29. Jarrett RJ, McCartney P, Keen H. The Bedford Survey: ten year mortality rates in newly diagnosed diabetes, borderline diabetes and normoglycemic controls and risk for coronary heart disease in borderline diabetics. Diabetologia. 1982;22:79-84.
30. Ferrara A, Barrett-Connor EL, Edelstein SL. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men and women without diabetes: the Rancho-Bernardo Study, 1984-91. Am J Epidemiol. 1994;40:857-869.
31. Orchard TJ, Eichner J, Kuller LH, Becker DJ, McCallum LM, Grandits GA. Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype - a report from the Multiple Risk Factor Intervention Trial. Ann Epidemiol. 1994;4: 40-45.
32. Hargreaves AD, Logan RL, Elton RA, Buchanan KD, Oliver MF, Riemersma RA. Glucose tolerance, plasma insulin. HDL cholesterol and obesity: 12-yr follow-up and development of coronary heart disease in Edinburgh men. Atherosclerosis. 1992;94:61-69.
33. Lillioja S, Young AA, Culter CL, Ivy JL, Abbott WGH, Zawadski JK, Yki-Jarvinen H, Christin L, Secomb TW, Bogardus C. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest. 1987:80:415-424.
34. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JN, Ward WK, Beard JC, Palmer JP, Porte D Jr. Quantification of the relationship between insulin sensitivity and B-cell function in human subjects: evidence for a hyperbolic function. Diabetes. 1993;42:1663-1672.
35. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol. 1993;137:959-965.
36. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyorala K, Salonen JT, Karhapaa P. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb. 1991;11:1068-1076.
37. Agewall S, Fagerberg B, Attvall S, Wendelhag I, Urbanavicius V, Wikstrand J. Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke. 1995;26:956-960.
38. Bonora E, Tessari R, Micciolo R, Zenere M, Targher G, Padovani R, Falezza G, Muggeo M. Intimal-medial thickness of the carotid artery in nondiabetic and non-insulin-dependent diabetic subjects: relationship with insulin resistance. Diabetes Care. 1997;20:627-631.
39. Trovati M, Anfossi G, Cavalot F, Massucco P, Mularoni E, Emanuelli G. Insulin directly reduces platelet sensitivity to aggregating agents: studies in vitro and in vivo. Diabetes. 1988;37:780-786.
40. Trovati M, Mularoni EM, Burzacca S, Ponziani MC, Massucco P, Mattiello L, Piretto V, Cavalot F, Anfossi G. Impaired insulin-induced platelet anti-aggregating effect in obesity and obese NIDDM patients. Diabetes. 1995;44:1318-1322.
41. Wu FS, Zierler K. Calcium currents in rat myoballs and their inhibition by insulin. Endocrinology. 1989;125:2563-2572.
42. Epstein E, Sowers JR. Diabetes mellitus and hypertension. Hypertension. 1992;19:403-418.
43. Draznin B, Sussman KE, Eckel RH, Kao M, Yost T, Sherman NA. Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. J Clin Invest. 1988;82:1848-1852.
44. Solini A, Di Virgilio F, Trevisan M, Cipollina MR, Nosadini R, Crepaldi G. Role of glucose and insulin on calcium handling in type II diabetic patients with and without hypertension and microalbuminuria. Diabetologia. 1994;37(suppl 1):A46. Abstract.
45. Phair RD. Cellular calcium and atherosclerosis: a brief review. Cell Calcium. 1988;9:275-284.
46. Levy J, Gavin JR III, Sowers JR. Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med. 1994;96:260-273.
47. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94:1172-1179.
48. Baron AD, Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G. Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest. 1995;96:786-792.
49. Luscher TF. The endothelium as a target and a mediator of cardiovascular disease. Eur J Clin Invest. 1993;23:670-685.